Nipro
CompanyJapan
Nipro develops one asset. Mostly cell therapy; based in Japan.
- 1
- Asset
- Furthest stage
- Not known
- 0
- Trials
- 1
- Signal
Pipeline
1Autologous bone marrow-derived mesenchymal stem cells promote tissue repair following spinal cord injury.
Stage not known, Cell therapy
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Signals1